MicroPort CardioFlow Medtech Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Jeffrey R Lindstrom

Chief executive officer

CN¥4.0m

Total compensation

CEO salary percentage	59.8%
CEO tenure	1.1yrs
CEO ownership	n/a
Management average tenure	3.9yrs
Board average tenure	3.7yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Jeffrey R Lindstrom's remuneration changed compared to MicroPort CardioFlow Medtech's earnings?
Date	Total Compensation	Salary	Company Earnings
Jun 30 2024	n/a	n/a	-CN¥349m
Mar 31 2024	n/a	n/a	-CN¥410m
Dec 31 2023	CN¥4m	CN¥2m	-CN¥472m

Compensation vs Market: Jeffrey R's total compensation ($USD571.10K) is about average for companies of similar size in the German market ($USD815.10K).

Compensation vs Earnings: Insufficient data to compare Jeffrey R's compensation with company performance.

CEO

Jeffrey R Lindstrom (57 yo)

1.1yrs

Tenure

CN¥4,004,000

Compensation

Mr. Jeffrey R Lindstrom is President, Executive Director & General Manager of MicroPort CardioFlow Medtech Corporation from August 29, 2023. He served as senior director of engineering in Edwards Lifescien...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Jeffrey R Lindstrom	President	1.1yrs	CN¥4.00m	no data
Liang Zhao	Executive Director & First VP of Total Solutions	2.3yrs	CN¥3.91m	0.058% CN¥ 134.9k
Luying Yan	VP & Executive Director	4yrs	CN¥2.70m	0.042% CN¥ 96.8k
Xiangmei Li	Joint Company Secretary	3.9yrs	no data	no data
Lok Yee Chan	Joint Company Secretary	3.9yrs	no data	no data

3.9yrs

Average Tenure

43yo

Average Age

Experienced Management: 72X's management team is considered experienced (3.9 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Jeffrey R Lindstrom	President	1.1yrs	CN¥4.00m	no data
Liang Zhao	Executive Director & First VP of Total Solutions	2.3yrs	CN¥3.91m	0.058% CN¥ 134.9k
Luying Yan	VP & Executive Director	4yrs	CN¥2.70m	0.042% CN¥ 96.8k
Jonathan H. Chou	Independent Non-Executive Director	3.7yrs	CN¥254.00k	no data
Xia Wu	Non-Executive Director	5.1yrs	no data	no data
Guoming Chen	Non-Executive Chairman of the Board	4yrs	CN¥3.16m	0.031% CN¥ 71.1k
Junjie Zhang	Non-Executive Director	5.1yrs	no data	no data
Zhixiang Sun	Independent Non-Executive Director	3.7yrs	CN¥254.00k	no data
Jiandong Ding	Independent Non-Executive Director	3.1yrs	CN¥254.00k	0.0012% CN¥ 2.9k

3.7yrs

Average Tenure

47yo

Average Age

Experienced Board: 72X's board of directors are considered experienced (3.7 years average tenure).

MicroPort CardioFlow Medtech Management

Management criteria checks 3/4

Key information

Recent management updates

MicroPort CardioFlow Medtech Corporation, Annual General Meeting, Jun 26, 2024

MicroPort Cardioflow Medtech Corporation Announces Executive Changes

Less than half of directors are independent

Less than half of directors are independent

MicroPort CardioFlow Medtech Announces Appointment of Zhao Liang as Executive Director

MicroPort CardioFlow Medtech Corporation Announces Resignation of Wu Guojia as an Executive Director

Recent updates

Now 28% undervalued

First half 2024 earnings released: CN¥0.024 loss per share (vs CN¥0.076 loss in 1H 2023)

Now 56% undervalued after recent price drop

MicroPort CardioFlow Medtech Corporation to Report First Half, 2024 Results on Aug 28, 2024

Now 48% undervalued after recent price drop

Full year 2023 earnings released: CN¥0.20 loss per share (vs CN¥0.19 loss in FY 2022)

Forecast to breakeven in 2026

MicroPort CardioFlow Medtech Corporation, Annual General Meeting, Jun 26, 2024

Full year 2023 earnings released: CN¥0.20 loss per share (vs CN¥0.19 loss in FY 2022)

MicroPort CardioFlow Medtech Corporation to Report Fiscal Year 2023 Results on Mar 27, 2024

Microport Cardioflow Medtech Corporation Receives NMPA Approval for Registration Application of Anchorman LAAC System

MicroPort CardioFlow Medtech Corporation Completes Clinical Implantation Cases in Europe

MicroPort CardioFlow Medtech Corporation Announces First Two Clinical Applications of Third-Generation TAVI Product

First half 2023 earnings released: CN¥0.076 loss per share (vs CN¥0.052 loss in 1H 2022)

MicroPort Cardioflow Medtech Corporation Announces Executive Changes

MicroPort CardioFlow Medtech Corporation to Report First Half, 2023 Results on Aug 29, 2023

New major risk - Share price stability

New minor risk - Share price stability

Less than half of directors are independent

Full year 2022 earnings released: CN¥0.19 loss per share (vs CN¥0.079 loss in FY 2021)

Less than half of directors are independent

Microport Cardioflow Medtech Corporation Announces Registration in Colombia for Alwide Plus Balloon Catheter

First half 2022 earnings released: CN¥0.05 loss per share (vs CN¥0.031 loss in 1H 2021)

MicroPort CardioFlow Medtech Corporation to Report Q2, 2022 Results on Aug 29, 2022

MicroPort CardioFlow Medtech Corporation Provides Earnings Guidance for the Six Months Ended June 30, 2022

Microport Cardioflow Medtech Corporation Announces That the Transcatheter Mitral Valve Replacement System Independently Developed by the Group Was Successfully Applied by the Heart Team of Zhongshan Hospital

MicroPort CardioFlow Medtech Announces Appointment of Zhao Liang as Executive Director

Full year 2021 earnings released: CN¥0.079 loss per share (vs CN¥0.23 loss in FY 2020)

MicroPort CardioFlow Medtech Corporation Announces Resignation of Wu Guojia as an Executive Director

Less than half of directors are independent

Full year 2021 earnings released: CN¥0.08 loss per share (vs CN¥0.23 loss in FY 2020)

MicroPort CardioFlow Medtech Corporation, Annual General Meeting, Jun 22, 2022

MicroPort CardioFlow Medtech Corporation, Annual General Meeting, Jun 22, 2022

Microport Cardioflow Medtech Corporation Successfully Registered Vitaflow Liberty Transcatheter Aortic Valve Implantation System in Argentina

Microport Cardioflow Medtech Corporation Announces Ce Mark Registration Application for Vitaflow Libertytm

No longer forecast to breakeven

Forecast to breakeven in 2023

Independent Non-Executive Director Hualiang Jiang has left the company

MicroPort CardioFlow Medtech Corporation to Report Fiscal Year 2020 Results on Mar 30, 2021

CEO Compensation Analysis

CEO

Tenure

Compensation

Leadership Team

Average Tenure

Average Age

Board Members

Average Tenure

Average Age